Danaher Corp
Danaher Corp (DHR) Covered Calls
As of September 28, 2026, DHR has 133 covered call opportunities in the coming three months. Return ranges from 1.5 to 62.5% until expiration. Annualized return ranges from 10.6 to 361.4%. The nearest expiration is October 2, 2026. Maximum potential profit is $14,041.
Read more
Running DHR covered calls helps you generate consistent income from Danaher Corp's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Danaher Corp involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best DHR covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if DHR stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling DHR covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Danaher Corp covered call is worth writing.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers.
The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Income-focused investors, long-term DHR holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling DHR covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Danaher Corp covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryDiagnostics & Research
- SectorHealthcare
- IV percentile97.22% Elevated
- Market cap (M$)159,810
- 52 weeks high-6.37%
- 52 weeks low41.26%
- Analyst recommendationStrong Buy
1.41 - Target price$230.09
1.21% above the current stock price - Dividend—
- Payout ratio25.36%
- Earnings date2026-10-21
- P/E40.36
- Future P/E24.45
- EPS (ttm)5.63
- EPS growth next 5 years9.43%
As of September 28, 2026
| 2026-10-02 | 7 | 240.00 | 6.91 | 0.05 | 0.95 | 1556.00 | 6.93 | 361.42 | -0.02 | +0.10 | 5 | 0.90 |
| 2026-10-02 | 7 | 237.50 | 5.80 | 0.05 | 1.55 | 1306.00 | 5.82 | 303.35 | -0.02 | +0.14 | 5 | 1.50 |
| 2026-10-09 | 14 | 250.00 | 11.36 | 0.05 | 0.70 | 2556.00 | 11.39 | 296.84 | -0.02 | +0.06 | 1 | 0.65 |
| 2026-10-09 | 14 | 245.00 | 9.14 | 0.05 | 2.35 | 2056.00 | 9.16 | 238.78 | -0.02 | +0.14 | 0 | 2.30 |
| 2026-10-16 | 21 | 255.00 | 13.59 | 0.10 | 0.50 | 3061.00 | 13.64 | 237.00 | -0.04 | +0.05 | 7 | 0.40 |
| 2026-10-30 | 35 | 270.00 | 20.27 | 0.10 | 0.90 | 4561.00 | 20.32 | 211.88 | -0.04 | +0.05 | 10 | 0.80 |
| 2026-10-02 | 7 | 232.50 | 3.57 | 0.80 | 1.15 | 881.00 | 3.92 | 204.63 | -0.36 | +0.20 | 44 | 0.35 |
| 2026-10-16 | 21 | 250.00 | 11.36 | 0.30 | 0.75 | 2581.00 | 11.50 | 199.83 | -0.13 | +0.08 | 221 | 0.45 |
| 2026-11-20 | 56 | 290.00 | 29.18 | 0.25 | 0.60 | 6576.00 | 29.29 | 190.93 | -0.11 | +0.04 | 52 | 0.35 |
| 2026-10-30 | 35 | 265.00 | 18.05 | 0.10 | 1.45 | 4061.00 | 18.09 | 188.65 | -0.04 | +0.07 | 0 | 1.35 |
As of September 28, 2026
Sell covered calls with the data behind you
Find the best DHR covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→